Akari Therapeutics (AKTX) Goodwill (2024 - 2026)

Akari Therapeutics' Goodwill history runs 3 years deep, the most recent figure standing at $8.4 million for Q1 2026.

• In Q1 2026, Goodwill changed 0.0% year-over-year to $8.4 million; the TTM figure through Mar 2026 stood at $8.4 million (changed 0.0% YoY), while the FY2025 annual figure was $8.4 million, changed 0.36% from the prior year.
• Goodwill came in at $8.4 million for Q1 2026 at Akari Therapeutics, roughly flat from $8.4 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $8.4 million in Q1 2025 to a low of $8.4 million in Q4 2024.
• A 3-year average of $8.4 million and a median of $8.4 million in 2025 frame the typical range for Goodwill.
• Across the five-year window, Goodwill advanced 0.36% in 2025 and changed 0.0% in 2026, its largest moves.
• Akari Therapeutics' Goodwill stood at $8.4 million in 2024, then rose by 0.36% to $8.4 million in 2025, then changed by 0.0% to $8.4 million in 2026.
• According to Business Quant data, Goodwill over the past three periods registered $8.4 million, $8.4 million, and $8.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison